Updated May 2026 · SEC EDGAR data
How Did Biogen Inc. (BIIB) Perform?
Biogen Inc. (BIIB) is currently classified NEUTRAL on the EarningsCallAI operator signal, with HIGH confidence, drawn from 8 quarters of SEC EDGAR XBRL filings and earnings call commentary. Latest reported revenue is $2.5B. Revenue grew +0.5% year-over-year. EPS came in at $2.15, with net income of $319.5M. Sector: Healthcare.
Headline Numbers
What the NEUTRAL Signal Means
Biogen Inc. is currently classified NEUTRAL with high confidence. Recent quarters are roughly flat with no decisive trend in either direction; management commentary is steady-state. This is "business as usual" with no major up or down signal for operators in the same market.
Revenue Trajectory
Biogen Inc. reported revenue roughly flat year-over-year (+0.5%). Flat revenue at this scale signals either a maturing market, a competitive squeeze, or a deliberate transition (divestitures, segment exits) that would show up in segment commentary on the call.
Net income of $319.5M on $2.5B of revenue translates to a 12.9 percent net margin, healthy by S&P 500 standards. The company is converting top-line growth into bottom-line profit at a meaningful rate.
Quarterly Profile
| Metric | Value |
|---|---|
| Operator Signal | NEUTRAL |
| Signal Confidence | HIGH |
| Sector | Healthcare |
| Quarters Tracked | 8 |
How the Signal Is Calculated
The EarningsCallAI operator signal blends a quantitative read of revenue trajectory across the most recent four to eight quarters with a qualitative read of management commentary in the earnings call. Both inputs come from primary public sources: SEC EDGAR XBRL filings for structured financials, and SEC Form 8-K earnings releases for management commentary. Where the two inputs agree, signal confidence is HIGH; where they conflict, confidence drops. Read the full methodology for the formal classification rules.
Frequently Asked Questions
How did Biogen Inc. perform in its latest earnings report?
Biogen Inc. reported $2.5B in revenue and $2.15 EPS in the most recent quarter filed on SEC EDGAR. Year-over-year revenue growth was +0.5%. The current operator signal is NEUTRAL with HIGH confidence.
What does Biogen Inc.'s NEUTRAL signal mean?
NEUTRAL means recent results are roughly flat with no decisive direction. The business is in steady state.
Where does Biogen Inc.'s data come from?
All structured financials, revenue, EPS, net income, growth rates, are pulled directly from Biogen Inc.'s SEC EDGAR XBRL filings (10-K, 10-Q). Operator signal classification is EarningsCallAI methodology, applied consistently across all S&P 500 companies and updated each earnings season. EDGAR data is in the public domain.
What sector is Biogen Inc. in?
Biogen Inc. is classified in the Healthcare sector. The classification follows standard S&P 500 sector taxonomy. To see how Biogen Inc. compares to other companies in the same sector, browse the sector page or use the side-by-side comparison tool.
Is the NEUTRAL signal investment advice?
No. The operator signal is built for business operators evaluating market demand and competitive trends, not for stock trading decisions. A TAILWIND signal does not mean buy the stock; a HEADWIND signal does not mean sell. Always consult a licensed financial advisor before making investment decisions.
Biogen Inc. (BIIB) is currently classified NEUTRAL on the EarningsCallAI operator signal, with HIGH confidence, drawn from 8 quarters of SEC EDGAR XBRL filings and earnings call commentary. Latest reported revenue is $2.5B. Revenue grew +0.5% year-over-year. EPS came in at $2.15, with net income of $319.5M. Sector: Healthcare.